65109

Alzheimer’s Drug Poses a Dilemma for the F.D.A.

0fdfc83ce0cd54a8f36531e731610ca2
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.

Latest Post